Moreover, a substantial methodological heterogeneity, including inconsistent protocols, lack of blinding, and unclear randomisation, limits the robustness of the conclusions
Since 2009, Russian authorities have authorized Selank for therapy in GAD [1]
Using a long-term HFD-fed mouse model of NAFLD, we demonstrated in this study that NAFLD development occurs concomitantly with dysregulated hepatic glutathione homeostasis characterized by decreased GSH and increased GSSG, and increased TNF protein levels in both the circulation and the liver
This means it produces a quick, physiologically normal GH pulse and then clears the system
The absence of safety data in these populations means that use should be avoided or approached with extreme caution and specialized medical supervision